EASL | The Home of Hepatology’s Post

🔬 The Hidden Connection: COVID-19 and Kidney Issues! 🌡️😷 Did you know that COVID-19 can directly impact your kidneys? 🦠💔 Recent studies have revealed that the virus invades renal cells, causing acute kidney injury and complications for patients. Get the latest insights on the surprising link between COVID-19 and kidney issues in our informative article from Encyclopedia MDPI! 📚🔬 Stay informed and stay protected! 🔗 Read the full text here: https://lnkd.in/gm2Q9RNz #COVID19 #KidneyDamage #HealthResearch #MedicalScience

🌐 Liver disease accounts for 2 million deaths annually, however, it is thought that 90% of cases of liver disease could be prevented. Exhaled breath is enriched with compounds that are associated with many different mechanisms associated with liver disease. 📑 Our ‘Breath Analysis and the Liver 101’ document highlights everything you need to know about how breath analysis can be used in liver disease research. We answer 3 major questions: 1️⃣ Why use breath? 2️⃣ What data do we have? 3️⃣ How can Owlstone Medical help? For everything you need to know about breath analysis and liver disease, download your free copy of our Liver 101 document here: https://ow.ly/wvZ950SbwCG #liver #liverdisease #breathanalysis

🌟 Update in Liver Health! 🌐🩺 #NAFLD has evolved into #MAFLD! 🔄 Embracing the change to Metabolic Associated Fatty Liver Disease to better capture its multifaceted nature. Let's foster awareness, collaboration, and research in this dynamic field. Join the discussion! 👩⚕️💼 #LiverHealth #MedicalAdvancements #HealthcareUpdate

The terminology for liver conditions is evolving! Non-Alcoholic Fatty Liver Disease (NAFLD) is now reclassified as Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD). This new term better reflects the metabolic factors driving the condition, leading to improved diagnosis and treatment Read More: https://lnkd.in/gTi_Ahje. Stay informed and proactive about your liver health with insights from Dr. Karthik Mathivanan at Liverindia.in. #LiverHealth #MASLD #MetabolicHealth #metabolichealth #metabolichealth

Join national obesity experts for an interactive, case-based discussion that includes an overview of old and new approaches to fatty liver disease and tips on optimizing cardiorenal disease in the presence of obesity. Through this webinar, you will gain a comprehensive understanding of how to assess and manage the complications of #obesity. https://bit.ly/3Rcxuf6

Did you know? MASH, or metabolic dysfunction-associated steatohepatitis, is a serious, progressive, metabolic disease affecting the liver, which can be fatal if not managed properly. It is often described as a ‘silent disease’ due to the lack of specific symptoms in the early stages of the disease, which often contributes to a delay in diagnosis. 13 June is Global #FattyLiverDay 🌎 Learn more about living with the condition and the impact of a late diagnosis from Tania. Watch Tania’s story here: https://lnkd.in/dAw55qZV At Novo Nordisk, we are committed to continuing our research with the ambition of developing innovations that can help address the underlying cause of this disease. We hope to double diagnostic rates for people living with moderate to advanced MASH by 2027 💙

"Polycystic Kidney Disease, the most common inherited kidney disease, has confounded doctors for years because there was/is no treatment for it. New research has revealed that there is something you can do to prevent or improve PKD at any stage. Typical doctor's advice for patients with polycystic kidney disease, including avoiding red meat, protein, caffeine, etc., are not backed by any research and don't help you at all. Everyone with PKD deserves to watch this video!" https://lnkd.in/e5qJ5Q6F

Today is #WorldLupusDay Lupus is a systemic autoimmune disease marked by a broad spectrum of clinical symptoms that vary unpredictably over time, typically affecting young women between 16 and 55 years and involving almost all organs and tissues. Discover how the European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases is facilitating cross-border collaboration to tackle this disease: https://lnkd.in/du2wRsXW

Enjoy the latest edition of ISN-ACT Global Trials Focus (GTF), a monthly list identifying and summarizing recent interesting trials relevant to kidney disease. Each trial is reviewed in context and assessed for its risk of bias in key areas ➡ https://ow.ly/z4H750T1ZWX ➡️ The TOM of this month goes to the FLOW trial, showing the FLOWing Benefits of Semaglutide in People with Type 2 Diabetes and CKD published NEJM. ➡️ Spironolactone didn't show any benefit on Kidney Function in Kidney Transplant Recipients. The SPIREN trial results were published CJASN. This scientific resource is made available to the global kidney health community thanks to the continued support of ISN Members. Renew/join the ISN and help us advance kidney health - together ➡️ https://ow.ly/ByKk50T1ZWY #ThisIsISN - Advancing kidney health worldwide. Together.

Imagine if this is how you saw the world. We’re on a mission to stop vision loss caused by chronic retinal diseases through earlier detection, intervention, and better treatments. Learn more about how we're building a diverse retinal health portfolio focused on the three main drivers of retinal disease: ➡️ Neurodegeneration (when nerve cells in the eye start to break down or die) ➡️ Inflammation ➡️ Vascular dysfunction (when the blood vessels start to fail or get blocked) 👉 https://lnkd.in/gQYEyNC4 #RetinalDiseases #RetinalHealth #Science